VAERS Explorer
Back to explore

Report #2881693

Received Jan 13, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (1)

Palpitations

Symptom narrative

heart palpitations; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of palpitation in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced palpitation (Verbatim: heart palpitations). The outcome of the palpitation was not resolved. It was unknown if the reporter considered the palpitation to be related to Shingrix. It was unknown if the company considered the palpitation to be related to Shingrix. Additional Information: GSK Receipt Date: 07-JAN-2026 This case was reported via interactive digital media. Patient had heart palpitations the morning after his first Shingrix shot, he did not call his doctor at the time, reporter wanted to know what should be done about the second shot. The batch number was not provided, and we are unable to contact the reporter.